N-(4-Chlorobenzyl)piperidine-4-amine dihydrochloride, 95.0%, 1g

4-(2-Fluoro-4-nitrophenyl)morpholine, 97.0%, 1g

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, for peptide synthesis, glass packaging

3-Chloroisoquinolin-7-boronic acid, 97%, 1g

4-iso-Propoxyphenylboronic acid, 97.0%, 10g

1-(2-phenylpropyl)piperazine, 95.0%, 1g

4-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]butanoic acid, 95.0%, 1g

3-Iodoisopropylbenzene, 1g

3'-Fluoro-4'-hydroxyacetophenone, 98.0%, 10g

(R)-1,1,1-Trifluoropropan-2-ol, 98%, 10g

(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoic acid, 95+%, 250mg

Sodium iodide 99+% USP, Ph. Eur 500 gram

6-methyl-2-piperidin-4-yl-1,3-benzoxazole, 250mg